Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated statement of cash flows

v3.24.1.1.u2
Consolidated statement of cash flows - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Cash generated from/(used in) operations € (30,681) € (95,704) € (2,921)
Interest paid (14,792) (9,224) (5,996)
Interest received 1,156 0 0
Proceeds from settlement of interest cap derivatives 0 1,071 0
Payment of interest cap derivative premiums 0 (4,068) 0
Income taxes received/(paid) (852) (424) (296)
Net cash flows from/(used in) operating activities (45,169) (108,349) (9,213)
Cash flows from investing activities      
Acquisition of Mega-E, net of cash acquired 0 (9,720) 0
Acquisition of MOMA, net of cash acquired 0 (58,644) 0
Purchase of property, plant and equipment (69,060) (25,581) (9,983)
Proceeds from sale of property, plant and equipment 0 45 1,207
Purchase of intangible assets 0 (1,572) (6,793)
Proceeds from government grants 137 512 1,702
Other cash flows used in investing activities 17 0 (1,500)
Net cash flows from/(used in) investing activities (68,906) (94,960) (15,367)
Cash flows from financing activities      
Proceeds from borrowings 82,400 159,210 44,315
Repayment of borrowings 0 (23,403) 0
Payment of principal portion of lease liabilities (4,692) (5,227) (3,215)
Payment of transaction costs on new equity instruments (498) (925) (134)
Payment of transaction costs on borrowings (1,576) (10,751) 0
Net cash flows from/(used in) financing activities 75,634 261,673 40,966
Net increase/(decrease) in cash and cash equivalents (38,441) 58,364 16,386
Cash and cash equivalents at the beginning of the year 83,022 24,652 8,274
Effect of exchange rate changes on cash and cash equivalents 4 6 (8)
Cash and cash equivalents at the end of the year 44,585 83,022 24,652
Spartan Shareholders      
Cash flows from financing activities      
Proceeds from issuing equity instruments 0 10,079 0
PIPE financing      
Cash flows from financing activities      
Proceeds from issuing equity instruments € 0 € 132,690 € 0